Advancing Measurement Through Imaging and Biomarkers

OMERACT Imaging and Biomarker Working Groups focus on developing, evaluating, and standardizing outcome measures derived from imaging technologies and biological samples. Their work ensures these instruments can be used reliably and reproducibly across clinical trials and observational studies.

By establishing clear definitions, scoring methods, and validation frameworks, these groups help transform complex data from MRI scans and ultrasound images to tissue and molecular analyses into meaningful and interpretable outcomes that support better clinical decision-making and research comparability.